Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. ($TNXP), made one open market purchase of shares worth $86,200 in the last 365 days. His most recent buy occurred on May 15, 2025. This ranks 2,531st among 4,983 insiders by purchase value, well below the average of $1.5 million over about 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 31, 2026 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | P | Common Stock, $0.001 par value | 5000 | $12.62 | 24,007.0000 | 10,168,204 | 26.31% | 0.05% |
| March 18, 2026 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | P | Common Stock, $0.001 par value | 15000 | $14.89 | 19,007.0000 | 10,168,204 | 374.34% | 0.15% |
| Feb. 24, 2026 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | A | Stock Option | 134503 | $0.00 | 134,503.0000 | 10,168,204 | 9999.99% | 1.32% |
| Feb. 24, 2026 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | A | Stock Option | 134504 | $0.00 | 134,504.0000 | 10,168,204 | 9999.99% | 1.32% |
| May 15, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | P | Common Stock, $0.001 par value | 4000 | $21.55 | 4,007.0000 | 5,590,667 | 9999.99% | 0.07% |
| Feb. 25, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | A | Stock Option | 123958 | $0.00 | 123,958.0000 | 5,590,667 | 9999.99% | 2.22% |
| Feb. 25, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | A | Stock Option | 123958 | $0.00 | 123,958.0000 | 5,590,667 | 9999.99% | 2.22% |
| Feb. 5, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | J | Common Stock, $0.001 par value | 5 | $3.38 | 13.0000 | 559,044,486 | 28.49% | 0.00% |
| Feb. 5, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | J | Common Stock, $0.001 par value | 0 | $3.30 | 13.0000 | 559,044,486 | 1.66% | 0.00% |
| Feb. 5, 2025 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | J | Common Stock, $0.001 par value | 1 | $0.15 | 13.0000 | 559,044,486 | 7.14% | 0.00% |
| Feb. 27, 2024 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | A | Stock Option | 1309911 | $0.00 | 1,309,911.0000 | 20,926 | 9999.99% | 100.00% |
| Feb. 27, 2024 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | A | Stock Option | 1903680 | $0.00 | 1,903,680.0000 | 20,926 | 9999.99% | 100.00% |
| Feb. 27, 2024 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | A | Stock Option | 235320 | $0.00 | 235,320.0000 | 20,926 | 9999.99% | 100.00% |
| Feb. 27, 2024 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | A | Stock Option | 235320 | $0.00 | 235,320.0000 | 20,926 | 9999.99% | 100.00% |
| Feb. 27, 2024 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | A | Stock Option | 1903680 | $0.00 | 1,903,680.0000 | 20,926 | 9999.99% | 100.00% |
| Feb. 27, 2024 | Tonix Pharmaceuticals Holding Corp. | $TNXP | LEDERMAN SETH | Chief Executive Officer | A | Stock Option | 1309911 | $0.00 | 1,309,911.0000 | 20,926 | 9999.99% | 100.00% |